Evidence map›Paper›PMID 40297700›Full record

ArticleResearch square2025

Glucuronidation Metabolomic Fingerprinting to Map Host-Microbe Metabolism.

Andrew Patterson, Nina Boyle, Josh John, Mingxun Wang, Helena Mannochio-Russo, Jeong Joo Pyo, Min Soo Kim, Shuchang Tian, Imhoi Koo, Mallappa Anitha and 8 more

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Andrew PattersonPennsylvania State University.ORCID 0000-0003-2073-0070
Nina BoylePenn State University.ORCID 0000-0003-0901-3775
Josh JohnUNC Chapel Hill.
Mingxun WangUniversity of California, Riverside.ORCID 0000-0001-7647-6097
Helena Mannochio-RussoUC San Diego.
Jeong Joo PyoPenn State University.
Min Soo KimPenn State University.
Shuchang TianPenn State University.
Imhoi KooPennsylvania State University.ORCID 0000-0002-5816-0627
Mallappa AnithaPenn State University.
Yuan TianPennsylvania State University.
Ethan MorganPenn State University.
Iain MurrayPenn State University.
Gary PerdewPenn State University.
Gary WuUniversity of Pennsylvania.ORCID 0000-0002-1829-8795
Pieter DorresteinUniversity of California San Diego.ORCID 0000-0002-3003-1030
Jordan BisanzPennsylvania State University.ORCID 0000-0002-8649-1706
Matthew RedinboUniversity of North Carolina at Chapel Hill.ORCID 0000-0003-0814-5346

Funding

Activation of the Ah receptor and epithelial integrityR35ES028244 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PERDEW, GARY H. · 2017 to 2024
$6.2M
Environmental Chemical Impact on the Host-Microbiome InteractionR35ES035027 · NIEHS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Andrew Patterson · 2023 to 2026
$3.6M
Collaborative Microbial Metabolite CenterU24DK133658 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PIETER C DORRESTEIN · 2022 to 2026
$2.9M
Gut Microbial Enzymes and Human DiseaseR35GM152079 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew R Redinbo · 2024 to 2026
$1.6M
Decoding Microbial Diversity in the Human Gut MicrobiomeR35GM151045 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Jordan Adam Bisanz · 2023 to 2026
$1.5M
Acquisition of an Orbitrap Fusion Lumos Tribid Mass Spectrometer to Accelerate Metabolite Identification and Pathway AnalysisS10OD021750 · OD · PENNSYLVANIA STATE UNIVERSITY, THE · PI PATTERSON, ANDREW · 2017 to 2017
$966k
Mapping the GlucuronidomeF31DK134090 · NIDDK · PENNSYLVANIA STATE UNIVERSITY, THE · PI BOYLE, NINA · 2023 to 2024
$73k
NIDDK NIH HHS F31 DK134090NIDDK NIH HHS U24 DK133658NIEHS NIH HHS R35 ES028244NIEHS NIH HHS R35 ES035027NIGMS NIH HHS R35 GM151045NIGMS NIH HHS R35 GM152079NIH HHS S10 OD021750
6 · The paper itself

Abstract

Glucuronidation is an important detoxification pathway that operates in balance with gastrointestinal microbial β-glucuronidase (GUS) enzymes that can regenerate active metabolites from their glucuronidated forms. Although significant progress has been made in characterizing GUS enzymes, methods to comprehensively define the glucuronidome - the collection of glucuronidated metabolites - remain limited. In this study we employed pattern-filtering data science approaches alongside untargeted LC-MS/MS metabolomics to map the glucuronidome in urine, serum, and colon/fecal samples from gnotobiotic and conventional mice. Our findings reveal microbiome-driven shifts in the glucuronidome, highlighting how differential GUS activity can influence host metabolite profiles. Reverse metabolomics of known glucuronidated chemicals and glucuronidation pattern filtering searches in public metabolomics datasets exposed the diversity of glucuronidated metabolites in human and mouse ecosystems. In summary, we present a new glucuronidation fingerprint resource that provides broader access to and analysis of the glucuronidome. By systematically capturing glucuronidation patterns, this resource enhances unknown metabolite annotation efforts and provides new insights into the dynamic relationship between the host and bacterial biotransformation activities.

Identifiers

PMID40297700
PMCPMC12036448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.